Advertisement FDA approves ParaPRO head lice medication - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA approves ParaPRO head lice medication

The US Food and Drug Administration (FDA) has approved ParaPRO's prescription medication, Natroba as a treatment for head lice in patients 4yearrs of age and older.

ParaPRO claims that the lice medication is an easy-to-use product and it resolves head lice problems within 10 minutes with just one application.

In two Phase III clinical studies, Natroba was more effective in eliminating head lice than permethrin 1% (marketed under the brand name Nix).

ParaPRO president Bill Culpepper III said Natroba is the only head lice treatment whose approval is supported by superiority studies versus permethrin 1%.

"FDA approval of Natroba is a significant step forward in the longstanding struggle to treat head lice infestations and we look forward to making the product available in pharmacies nationwide as soon as possible," Culpepper III said.